Home
RCKT

RCKT

Rocket Pharmaceuticals Inc.

as of 12-05-2025 3:46pm EST

$3.32

$0.10

-3.07%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

Chart Type:

Time Range:

Founded:	1999	Country:	United States
Employees:	N/A	City:	NEW YORK
Market Cap:	340.9M	IPO Year:	N/A
Target Price:	$29.12	AVG Volume (30 days):	2.0M
Analyst Decision:	Buy	Number of Analysts:	14
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-2.24	EPS Growth:	N/A
52 Week Low/High:	$2.19 - $15.00	Next Earning Date:	11-06-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered RCKT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold

Model Accuracy: 71.92%

71.92%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full RCKT Forecast & Prediction with Hourly Data

Compare RCKT vs Leading Stocks

See how RCKT stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free RCKT Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "RCKT Rocket Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.